CSL supports biomedical communities in a variety of ways, including through active participation in education and development programs and the support of biomedical research, primarily towards investigator-initiated studies.
We believe education and development programs are critical for advancing scientific knowledge and encouraging the best and brightest students to pursue higher education and undertake careers in medical research.
In 2016, CSL celebrated its 100-year anniversary and in honour of this milestone, in Melbourne on 25 April, CSL announced the establishment of a new flagship A$25 million fellowship program for discovery stage and translational research in Australia. The 20 high-value, long-term awards, valued at A$1.25 million each, are available to outstanding Australian researchers who are seeking to consolidate their career and undertake research in an Australian academic institution.
Our flagship centenary program is underpinned by longstanding initiatives that seek to foster the next generation of medical researchers, from programs such as the National Youth Science Forum and the Undergraduate Research Opportunities Program that encourage promising young students to pursue careers in biomedical research to mid-career and accomplished scientists striving to advance human health.
CSL's support for biomedical research comprises research grants to research institutes, hospitals and patient organisations. This includes support for investigator-initiated studies (IIS) which totalled US$5.1 million in 2015/16. IIS projects are undertaken independently of CSL and usually for the purposes of exploring additional use or application of one of our therapies, or conducting a research project to learn more about a particular disease state or product application.
SUPPORT FOR BIOMEDICAL COMMUNITY 2015/16
BREAKDOWN OF TOTAL BIOMEDICAL COMMUNITY CONTRIBUTIONS